Literature DB >> 29279192

The prevalence of PRKRA mutations in idiopathic dystonia.

Camila Oliveira Dos Santos1, Francisco Pereira da Silva-Júnior2, Renato David Puga1, Egberto Reis Barbosa2, Sonia Maria Cesar Azevedo Silva3, Vanderci Borges4, João Carlos Papaterra Limongi2, Maria Sheila Guimarães Rocha5, Henrique Ballalai Ferraz4, Patricia de Carvalho Aguiar6.   

Abstract

INTRODUCTION: DYT-PRKRA (DYT16) is considered a rare cause of dystonia-parkinsonism. The significance of this gene as a cause of dystonia and its phenotypical characterization must be determined in larger cohorts. We aimed to investigate the role of PRKRA in patients with dystonia.
METHODS: We sequenced PRKRA in 153 unrelated Brazilian patients with idiopathic dystonia. The frequency of novel missense variants was investigated in healthy Brazilian controls and in public databases. Homozygosity in the PRKRA region was assessed through polymorphic markers.
RESULTS: PRKRA variants were identified in seven probands with isolated dystonia, including a novel c.C795A variant in compound heterozygosity with the previously described c.C665T variant. Heterozygosity in the gene region was observed in two probands who were homozygous for c.C665T, indicating that this mutation originated from independent events, suggesting a hotspot.
CONCLUSION: PRKRA is not an unusual cause of idiopathic dystonia. In this cohort, it was responsible for 4.5% of the total of cases (4.9% of the isolated dystonia cases). The most common phenotype was early-onset isolated focal dystonia followed by generalization, parkinsonism was not observed. This is first report of PRKRA causing adulthood-onset dystonia. Screenings of large cohorts are recommended to investigate the role of this gene in isolated dystonia, as well as in dystonia-parkinsonism cases worldwide.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  DYT16; Dystonia; Dystonia-parkinsonism; Genetics; PRKRA

Mesh:

Substances:

Year:  2017        PMID: 29279192     DOI: 10.1016/j.parkreldis.2017.12.015

Source DB:  PubMed          Journal:  Parkinsonism Relat Disord        ISSN: 1353-8020            Impact factor:   4.891


  5 in total

1.  Imaging Evidence of Nigrostriatal Degeneration in DYT-PRKRA.

Authors:  Maria João Pinto; Ana Oliveira; Maria José Rosas; João Massano
Journal:  Mov Disord Clin Pract       Date:  2020-04-06

2.  The HIV protease inhibitor, ritonavir, corrects diverse brain phenotypes across development in mouse model of DYT-TOR1A dystonia.

Authors:  Zachary F Caffall; Bradley J Wilkes; Ricardo Hernández-Martinez; Joseph E Rittiner; Jennifer T Fox; Kanny K Wan; Miranda K Shipman; Steven A Titus; Ya-Qin Zhang; Samarjit Patnaik; Matthew D Hall; Matthew B Boxer; Min Shen; Zhuyin Li; David E Vaillancourt; Nicole Calakos
Journal:  Sci Transl Med       Date:  2021-08-18       Impact factor: 17.956

3.  PRKRAP1 Pseudogene Complicating the Diagnosis of Young-Onset Dystonia Due to PRKRA Gene Disease-Causing Variants (DYT-PRKRA).

Authors:  Joana Afonso Ribeiro; Mário Sousa; Isabel Alonso; Fradique Moreira; Ricardo Pereira; Filipe Palavra
Journal:  Mov Disord Clin Pract       Date:  2022-03-04

4.  DYT-PRKRA Mutation P222L Enhances PACT's Stimulatory Activity on Type I Interferon Induction.

Authors:  Lauren S Vaughn; Kenneth Frederick; Samuel B Burnett; Nutan Sharma; D Cristopher Bragg; Sarah Camargos; Francisco Cardoso; Rekha C Patel
Journal:  Biomolecules       Date:  2022-05-17

Review 5.  Combined dystonias: clinical and genetic updates.

Authors:  Anne Weissbach; Gerard Saranza; Aloysius Domingo
Journal:  J Neural Transm (Vienna)       Date:  2020-10-24       Impact factor: 3.575

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.